Literature DB >> 25346394

Apheresis in developing countries around the World.

Quentin Eichbaum1, W Martin Smid2, Robert Crookes3, Norris Naim4, Alfredo Mendrone5, José Francisco Comenalli Marques6, Marisa B Marques7.   

Abstract

At the combined American Society for Apheresis (ASFA) Annual Meeting/World Apheresis Association (WAA) Congress in San Francisco, California, in April of 2014, the opening session highlighted the status of apheresis outside of the United States. The organizers invited physicians active in apheresis in countries not usually represented at such international gatherings to give them a forum to share their experiences, challenges, and expectations in their respective countries with regard to both donor and therapeutic apheresis. Apheresis technology is expensive as well as technically and medically demanding, and low and median income countries have different experiences to share with the rest of the world. Apheresis procedures also require resources taken for granted in the developed world, such as reliable electrical power, that can be unpredictable in parts of the developing world. On the other hand, it was obvious that there are significant disparities in access to apheresis within the same country (such as in Brazil), as well as between neighboring nations in Africa and South America. A common trend in the presentations from Brazil, Indonesia, Malaysia, Nigeria, and South Africa, was the need for more and better physicians and practitioners' training in the indications of the various apheresis modalities and patient oversight during the procedures. As ASFA and WAA continue to work together, and globalization allows for increased knowledge-sharing, improved access to apheresis procedures performed by qualified personnel with safety and high-quality standards will be increasingly available.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Africa; Brazil; Malaysia; South Africa; donor apheresis; therapeutic apheresis

Mesh:

Year:  2014        PMID: 25346394     DOI: 10.1002/jca.21368

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  5 in total

1.  Recovery of platelet-rich red blood cells and acquisition of convalescent plasma with a novel gravity-driven blood separation device.

Authors:  Dion Osemwengie; Johan W Lagerberg; Richard Vlaar; Erik Gouwerok; Mya Go; Arno P Nierich; Dirk de Korte
Journal:  Transfus Med       Date:  2021-11-10       Impact factor: 2.057

2.  The social value of candidate HIV cures: actualism versus possibilism.

Authors:  Regina Brown; Nicholas Greig Evans
Journal:  J Med Ethics       Date:  2016-07-08       Impact factor: 2.903

3.  Maximising the global health impact of future HIV cure-related interventions through advance planning.

Authors:  Regina Brown; Steven G Deeks; Nir Eyal
Journal:  J Virus Erad       Date:  2018-07-01

Review 4.  Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients.

Authors:  Seena Tabibi; Tara Tabibi; Rosalynn R Z Conic; Nassim Banisaeed; Michael B Streiff
Journal:  J Intensive Care Med       Date:  2020-07-15       Impact factor: 3.510

5.  Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis.

Authors:  Charan T R Vegivinti; John M Pederson; Kavitha Saravu; Nitin Gupta; Kirk W Evanson; Shelby Kamrowski; Megan Schmidt; Averi Barrett; Hannah Trent; Mahmoud Dibas; Natalie L Reierson; Nick Mikoff; Sailaja Pisipati; Betsy A Joseph; Pragadeesh T Selvan; Adam A Dmytriw; Yashwitha S Pulakurthi; Praneeth R Keesari; Varsha Sriram; Spandana Chittajallu; Waleed Brinjikji; Rewanth R Katamreddy; Richa Chibbar; Amber R Davis; Manashree Malpe; Hemant K Mishra; Kevin M Kallmes; Ameer E Hassan
Journal:  J Clin Apher       Date:  2021-02-05       Impact factor: 2.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.